Vol. 24 No. 4 (2020)
FUNDAMENTAL RESEARCH

Identification of ethnogenetic differences in genetic markers in the clinical course and damage to target organs in arterial hypertension in Russians and Buryats

A. Kovaleva
Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
Bio
N. Kokh
Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
E. Voronina
Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
O. Donirova
N.A. Semashko Republican Clinical Hospital, Ulan-Ude
E. Zelenskаyа
Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
A. Slepukhina
Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
G. Lifshits
Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk

Published 2020-12-30

Keywords

  • аrteriаl hypertension,
  • Buryаts,
  • ethnogenetic differences,
  • genetic mаrkers

How to Cite

Kovaleva, A., Kokh, N., Voronina, E., Donirova, O., Zelenskаyа E., Slepukhina, A., & Lifshits, G. (2020). Identification of ethnogenetic differences in genetic markers in the clinical course and damage to target organs in arterial hypertension in Russians and Buryats. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 24(4), 103–113. https://doi.org/10.21688/1681-3472-2020-4-103-113

Abstract

Аim. To study the influence of genetic factors on the severity of essential аrteriаl hypertension (AH) clinical outcomes in patients of Russian and Buryаt ethnicity.
Methods. Our study included 206 patients with а diagnosis of essential AH: 136 patients were of Russiаn аnd 70 patients were of Buryаt ethnicity. Pаtients were evаluаted for the following genotype markers; АCE, АDRB1, АDRB2, АDRB3, NOS3, АGT, EDN1, GNB3, and STK39.
Results. Allele T of GNB3 was аssociаted with high blood pressure in Russiаn аnd Buryаt patients. In Buryat patients, locus rs934379 of EDN1 was аssociаted with high blood pressure, whereas allele G of the same marker was associated with increased heart damage risk. In Russians, allele I of ACE was protective towards the development of left ventricular hypertrophy.
Conclusion. Our data revealed ethnogenetic differences in the genetic features of essential AH. We identified the patients severe hypertension among two etnhic group. Studying ethnic genetic markers for essential AH facilitates a greater understanding of the genetic predisposition underlying this condition.

Received 2 July 2020. Revised 31 August 2020. Accepted 9 September 2020.

Funding: The work is supported by grant of the Russian Foundation for Basic Research (project No. 19-315-80032).

Conflict of interest: Authors declare no conflict of interest.

Author contributions
Conception and design: N.V. Kokh, E.M. Zelenskаyа, G.I. Lifshits
Data collection and analysis: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. Lifshits
Statistical analysis: N.V. Kokh
Drafting the article: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. Lifshits
Critical revision of the article: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. Lifshits
Final approval of the version to be published: A.Yа. Kovаlevа, N.V. Kokh, E.N. Voroninа, O.S. Donirovа, E.M. Zelenskаyа, A.A. Slepukhina, G.I. Lifshits

References

  1. Муромцева Г.А., Концевая А.В., Константинов В.В., Артамонова Г.В., Гатагонова Т.М., Дупляков Д.В., Ефанов А.Ю., Жернакова Ю.В., Ильин В.А., Конради А.О., Либис Р.А., Минаков А.В., Недогода С.В., Ощепкова Е.В., Романчук С.В., Ротарь О.П., Трубачева И.А., Деев А.Д., Шальнова С.А., Чазова И.Е., Шляхто Е.В., Бойцов С.А., Баланова Ю.А., Гомыранова Н.В., Евстифеева С.Е., Капустина А.В., Литинская О.А., Мамедов М.Н., Метельская В.А., Оганов Р.Г., Суворова Е.И., Худяков М.Б., Баранова Е.И., Касимов Р.А., Шабунова А.А., Ледяева А.А., Чумачек Е.В., Азарин О.Г., Бабенко Н.И., Бондарцов Л.В., Фурменко Г.И., Хвостикова А.Е., Белова О.А., Назарова О.А., Шутемова Е.А., Барбараш О.Л., Данильченко Я.В., Индукаева Е.В., Максимов С.А., Мулерова Т.А., Скрипченко А.Е., Черкасс Н.В., Басырова И.Р., Исаева Е.Н., Кондратенко В.Ю., Лопина Е.А., Сафонова Д.В., Гудкова С.А., Черепанова Н.А., Кавешников В.С., Карпов Р.С., Серебрякова В.Н., Медведева И.В., Сторожок М.А., Шава В.П., Шалаев С.В., Гутнова С.К., Толпаров Г.В. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования эссе-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4-11. [Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V., Artamonova G.V., Gatagonova T.M., Duplyakov D.V., Efanov A.Yu., Zhernakova Yu.V., Il'in V.A., Konradi A.O., Libis R.A., Minakov E.V., Nedogoda S.V., Oschepkova E.V., Romanchuk S.V., Rotar O.P., Trubacheva I.A., Deev A.D., Shalnova S.A., Chazova I.E., Shlyakhto E.V., Boytsov S.A., Balanova Yu.A., Gomyranova N.V., Evstifeeva S.E., Kapustina A.V., Litinskaya O.A., Mamedov M.N., Metelskaya V.A., Oganov R.G., Suvorova E.I., Khudyakov M.B., Baranova E.I., Kasimov R.A., Shabunova A.A., Ledyaeva A.A., Chumachek E.V., Azarin O.G., Babenko N.I., Bondartsov L.V., Furmenko G.I., Hvostikova A.E., Belova O.A., Nazarova O.A., Shutemova E.A., Barbarash O.L., Danilchenko Ya.V., Indukaeva E.V., Maksimov S.A., Mulerova T.A., Skripchenko A.E., Cherkass N.V., Basirova I.R., Isaeva E.N., Kondratenko V.Yu., Lopina E.A., Safonova D.V., Gudkova S.A., Cherepanova N.A., Kaveshnikov V.S., Karpov R.S., Serebryako-va V.N., Medvedeva I.V., Storozhok M.A., Shava V.P., Shalaev S.V., Gutnova S.K., Tolparov G.V. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of Esse-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4-11. (In Russ.)] https://doi.org/10.15829/1728-8800-2014-6-4-11
  2. Ettehad D., Emdin C.A., Kiran A., Anderson, S.G., Callender T., Emberson J., Chalmers J., Rodgers A., Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-967. PMID: 26724178. https://doi.org/10.1016/S0140-6736(15)01225-8
  3. Чазова И.Е., Жернакова Ю.В. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;16(1):6-31. [Chazova I.E., Zhernakova Yu.V. Diagnosis and treatment of arterial hypertension. Systemic Hypertension. 2019;16(1):6-31. (In Russ.)] https://doi.org/10.26442/2075082X.2019.1.190179
  4. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D.L., Coca A., de Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S.E., Kreutz R., Laurent S., Lip G.Y.H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R.E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I., Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. PMID: 30234752. https://doi.org/10.1097/HJH.0000000000001940
  5. Vishram J.K.K., Borglykke А., Andreasen А.H., Jeppesen J., Ibsen H., Jørgensen T., Broda G., Palmieri L., Giampaoli S., Donfrancesco C., Kee F., Mancia G., Cesana G., Kuulasmaa K., Sans S., Olsen M.H., MORGАM Project. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) project. Hypertension. 2012;60(5):1117-1123. PMID: 23006731. https://doi.org/10.1161/HYPERTENSIONAHA.112.201400
  6. Цэцэгдулам Б., Максикова Т.М., Калягин А.Н., Орлова Г.М., Синькова Г.М., Балабина Н.М. Ретроспективный анализ структуры факторов риска сердечнососудистых заболеваний у больных артериальной гипертензией в Монголии. Артериальная гипертензия. 2019;25(1):14-24. [Tsetsegdulam B., Maksikova T.M., Kalyagin A.N., Orlova G.M., Sinkova G.M., Balabina N.M. Retrospective analysis of the cardiovascular risk factors in hypertensive patients in Mongolia. Arterial Hypertension. 2019;25(1):14-24. (In Russ.)] https://doi.org/10.18705/1607-419X-2019-25-1-14-24
  7. Ощепкова Е.В., Лазарева Н.В., Чазова И.Е. Оценка качества обследования больных артериальной гипертонией в первичном звене здравоохранения (по данным российского Регистра артериальной гипертонии). Системные гипертензии. 2017;14(2):29-34. [Oshchepkova E.V., Lazareva N.V., Chazova I.E. Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data). Systemic Hypertension. 2017;14(2):29-34. (In Russ.)] https://doi.org/10.26442/2075-082X_14.2.29-34
  8. Ершова О.А., Баирова Т.А. Распространенность полиморфизма -262С/Т гена каталазы (rs1001179) у русских и бурят Восточной Сибири с эссенциальной артериальной гипертензией. Acta Biomedica Scientifica. 2015;(3):70-73. [Ershova O.A., Bairova T.A. Polymorphism -262C/T of catalase gene (rs1001179) in Russian and Buryat populations with essential hypertension living in the Eastern Siberia. Acta Biomedica Scientifica. 2015;(3):70-73. (In Russ.)]
  9. Зеленская Е.М., Николаев К.Ю., Донирова О.С., Алтаев В.Д., Протасов К.С., Воронина Е.Н., Лифшиц Г.И. Ассоциация генетических детерминант метаболизма клопидогрела и клинических показателей сердечно-сосудистого риска у пациентов бурятской национальности. Патология кровообращения и кардиохирургия. 2019;23(3):39-46. [Zelenskaya Е.М., Nikolaev K.Y., Donirova O.S., Altayev V.D., Protasov K.V., Voronina E.N., Lifshits G.I. Association between genetic determinants of clopidogel metabolism and clinical cardiovascular risk indicators in buryat patients. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2019;23(3):39-46. (In Russ.)] https://doi.org/10.21688/1681-3472-2019-3-39-46
  10. Devos P., Menard J. Bibliometric analysis of research relating to hypertension reported over the period 1997-2016. J Hypertens. 2019;37(11):2116-2122. PMID: 31136459, PMCID: PMC6784761. https://doi.org/10.1097/HJH.0000000000002143
  11. Ковалева А.Я., Кох Н.В., Воронина Е.Н., Донирова О.С., Зеленская Е.М., Лифшиц Г.И. Связь генетических факторов риска с развитием артериальной гипертонии с учётом этнических различий. Российский кардиологический журнал. 2019;24(10):66-71. [Kovaleva A.Ya., Kokh N.V., Voronina E.N., Donirova O.S., Zelenskaya E.M., Lifshits G.I. The relationship of genetic risk factors with the development of arterial hypertension taking into account ethnic differences. Russian Journal of Cardiology. 2019;24(10):66-71. (In Russ.)] https://doi.org/10.15829/1560-4071-2019-10-66-71
  12. Tang H., Quertermous T., Rodriguez B., Kardia S.L.R., Zhu X., Brown A., Pankow J.S., Province M.A., Hunt S.C., Boerwinkle E., Schork N.J., Risch N.J. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet. 2005;76(2):268-275. PMID: 15625622, PMCID: PMC1196372. https://doi.org/10.1086/427888
  13. Бойцов С.А., Демкина А.Е., Ощепкова Е.В., Долгушева Ю.А. Достижения и проблемы практической кардиологии в России на современном этапе. Кардиология. 2019;59(3):53-59. [Boytsov S.A., Demkina A.E., Oshchepkova E.V., Dolgushe-va Yu.A. Progress and problems of practical cardiology in Russia at the present stage. Kardiologiia. 2019;59(3):53-59. (In Russ.)] https://doi.org/10.18087/cardio.2019.3.10242
  14. Semplicini А., Grandi Т., Sandona С., Cattelan A., Ceolotto G. G-protein β3-subunit gene C825T polymorphism and cardiovascular risk: an updated review. High Blood Press Cаrdiovаsc Prev. 2015;22(3):225-232. PMID: 25903425. https://doi.org/10.1007/s40292-015-0093-4
  15. Ehret G.B., Ferreira T., Chasman D.I., Jackson A.U., Schmidt E.M., Johnson T., Thorleifsson G., Luan J., Donnelly L.A., Kanoni S., Petersen A.K., Pihur V., Strawbridge R.J., Shungin D., Hughes M.F., Meirelles O., Kaakinen M., Bouatia-Naji N., Kristiansson K., Shah S., Kleber M.E., Guo X., Lyytikäinen L.P., Fava C., Eriksson N., Nolte I.M., Magnusson P.K., Salfati E.L., Rallidis L.S., Theusch E., Smith A.J.P., Folkersen L., Witkowska K., Pers T.H., Joehanes R., Kim S.K., Lataniotis L., Jansen R., Johnson A.D., Warren H., Kim Y.J., Zhao W., Wu Y., Tayo B.O., Bochud M.; CHARGE-EchoGen consortium; CHARGE-HF consortium; Wellcome Trust Case Control Consortium, Absher D., Adair L.S., Amin N., Arking D.E., Axelsson T., Baldassarre D., Balkau B., Bandinelli S., Barnes M.R., Barroso I., Bevan S., Bis J.C., Bjornsdottir G., Boehnke M., Boerwinkle E., Bonnycastle L.L., Boomsma D.I., Bornstein S.R., Brown M.J., Burnier M., Cabrera C.P., Chambers J.C., Chang I.S., Cheng C.Y., Chines P.S., Chung R.H., Collins F.S., Connell J.M., Döring A., Dallongeville J., Danesh J., de Faire U., Delgado G., Dominiczak A.F., Doney A.S.F., Drenos F., Edkins S., Eicher J.D., Elosua R., Enroth S., Erdmann J., Eriksson P., Esko T., Evangelou E., Evans A., Fall T., Farrall M., Felix J.F., Ferrières J., Ferrucci L., Fornage M., Forrester T., Franceschini N., Duran O.H.F., Franco-Cereceda A., Fraser R.M., Ganesh S.K., Gao H., Gertow K., Gianfagna F., Gigante B., Giulianini F., Goel A., Goodall A.H., Goodarzi M.O., Gorski M., Gräßler J., Groves C., Gudnason V., Gyllensten U., Hallmans G., Hartikainen A.L., Hassinen M., Havulinna A.S., Hayward C., Hercberg S., Herzig K.H., Hicks A.A., Hingorani A.D., Hirschhorn J.N., Hofman A., Holmen J., Holmen O.L., Hottenga J.J., Howard P., Hsiung C.A., Hunt S.C., Ikram M.A., Illig T., Iribarren C., Jensen R.A., Kähönen M., Kang H., Kathiresan S., Keating B.J., Khaw K.T., Kim Y.K., Kim E., Kivimaki M., Klopp N., Kolovou G., Komulainen P., Kooner J.S., Kosova G., Krauss R.M., Kuh D., Kutalik Z., Kuusisto J., Kvaløy K., Lakka T.A., Lee N.R., Lee I.T., Lee W.J., Levy D., Li X., Liang K.W., Lin H., Lin L., Lindström J., Lobbens S., Männistö S., Müller G., Müller-Nurasyid M., Mach F., Markus H.S., Marouli E., McCarthy M.I., McKenzie C.A., Meneton P., Menni C., Metspalu A., Mijatovic V., Moilanen L., Montasser M.E., Morris A.D., Morrison A.C., Mulas A., Nagaraja R., Narisu N., Nikus K., O'Donnell C.J., O'Reilly P.F., Ong K.K., Paccaud F., Palmer C.D., Parsa A., Pedersen N.L., Penninx B.W., Perola M., Peters A., Poulter N., Pramstaller P.P., Psaty B.M., Quertermous T., Rao D.C., Rasheed A., Rayner N.W.N.W.R., Renström F., Rettig R., Rice K.M., Roberts R., Rose L.M., Rossouw J., Samani N.J., Sanna S., Saramies J., Schunkert H., Sebert S., Sheu W.H., Shin Y.A., Sim X., Smit J.H., Smith A.V., Sosa M.X., Spector T.D., Stančáková A., Stanton A., Stirrups K.E., Stringham H.M., Sundstrom J., Swift A.J., Syvänen A.C., Tai E.S., Tanaka T., Tarasov K.V., Teumer A., Thorsteinsdottir U., Tobin M.D., Tremoli E., Uitterlinden A.G., Uusitupa M., Vaez A., Vaidya D., van Duijn C.M., van Iperen E.P.A., Vasan R.S., Verwoert G.C., Virtamo J., Vitart V., Voight B.F., Vollenweider P., Wagner A., Wain L.V., Wareham N.J., Watkins H., Weder A.B., Westra H.J., Wilks R., Wilsgaard T., Wilson J.F., Wong T.Y., Yang T.P., Yao J., Yengo L., Zhang W., Zhao J.H., Zhu X., Bovet P., Cooper R.S., Mohlke K.L., Saleheen D., Lee J.Y., Elliott P., Gierman H.J., Willer C.J., Franke L., Hovingh G.K., Taylor K.D., Dedoussis G., Sever P., Wong A., Lind L., Assimes T.L., Njølstad I., Schwarz P.E., Langenberg C., Snieder H., Caulfield M.J., Melander O., Laakso M., Saltevo J., Rauramaa R., Tuomilehto J., Ingelsson E., Lehtimäki T., Hveem K., Palmas W., März W., Kumari M., Salomaa V., Chen Y.I., Rotter J.I., Froguel P., Jarvelin M.R., Lakatta E.G., Kuulasmaa K., Franks P.W., Hamsten A., Wichmann H.E., Palmer C.N.A., Stefansson K., Ridker P.M., Loos R.J.F., Chakravarti A., Deloukas P., Morris A.P., Newton-Cheh C., Munroe P.B. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 2016;48(10):1171-1184. PMID: 27618452, PMCID: PMC5042863. https://doi.org/10.1038/ng.3667
  16. Surendran P., Drenos F., Young R., Warren H., Cook J.P., Manning A.K., Grarup N., Sim X., Barnes D.R., Witkowska K., Staley J.R., Tragante V., Tukiainen T., Yaghootkar H., Masca N., Freitag D.F., Ferreira T., Giannakopoulou O., Tinker A., Harakalova M., Mihailov E., Liu C., Kraja A.T., Fallgaard Nielsen S., Rasheed A., Samuel M., Zhao W., Bonnycastle L.L., Jackson A.U., Narisu N., Swift A.J., Southam L., Marten J., Huyghe J.R., Stančáková A., Fava C., Ohlsson T., Matchan A., Stirrups K.E., Bork-Jensen J., Gjesing A.P., Kontto J., Perola M., Shaw-Hawkins S., Havulinna A.S., Zhang H., Donnelly L.A., Groves C.J., Rayner N.W., Neville M.J., Robertson N.R., Yiorkas A.M., Herzig K.H., Kajantie E., Zhang W., Willems S.M., Lannfelt L., Malerba G., Soranzo N., Trabetti E., Verweij N., Evangelou E., Moayyeri A., Vergnaud A.C., Nelson C.P., Poveda A., Varga T.V., Caslake M., de Craen A.J., Trompet S., Luan J., Scott R.A., Harris S.E., Liewald D.C., Marioni R., Menni C., Farmaki A.E., Hallmans G., Renström F., Huffman J.E., Hassinen M., Burgess S., Vasan R.S., Felix J.F.; CHARGE-Heart Failure Consortium, Uria-Nickelsen M., Malarstig A., Reily D.F., Hoek M., Vogt T., Lin H., Lieb W.; EchoGen Consortium, Traylor M., Markus H.F.; METASTROKE Consortium, Highland H.M., Justice A.E., Marouli E.; GIANT Consortium, Lindström J., Uusitupa M., Komulainen P., Lakka T.A., Rauramaa R., Polasek O., Rudan I., Rolandsson O., Franks P.W., Dedoussis G., Spector T.D.; EPIC-InterAct Consortium, Jousilahti P., Männistö S., Deary I.J., Starr J.M., Langenberg C., Wareham N.J., Brown M.J., Dominiczak A.F., Connell J.M., Jukema J.W., Sattar N., Ford I., Packard C.J., Esko T., Mägi R., Metspalu A., de Boer R.A., van der Meer P., van der Harst P.; Lifelines Cohort Study, Gambaro G., Ingelsson E., Lind L., de Bakker P.I., Numans M.E., Brandslund I., Christensen C., Petersen E.R., Korpi-Hyövälti E., Oksa H., Chambers J.C., Kooner J.S., Blakemore A.I., Franks S., Jarvelin M.R., Husemoen L.L., Linneberg A., Skaaby T., Thuesen B., Karpe F., Tuomilehto J., Doney A.S., Morris A.D., Palmer C.N., Holmen O.L., Hveem K., Willer C.J., Tuomi T., Groop L., Käräjämäki A., Palotie A., Ripatti S., Salomaa V., Alam D.S., Shafi Majumder A.A., Di Angelantonio E., Chowdhury R., McCarthy M.I., Poulter N., Stanton A.V., Sever P., Amouyel P., Arveiler D., Blankenberg S., Ferrières J., Kee F., Kuulasmaa K., Müller-Nurasyid M., Veronesi G., Virtamo J., Deloukas P.; Wellcome Trust Case Control Consortium, Elliott P; Understanding Society Scientific Group, Zeggini E., Kathiresan S., Melander O., Kuusisto J., Laakso M., Padmanabhan S., Porteous D., Hayward C., Scotland G., Collins F.S., Mohlke K.L., Hansen T., Pedersen O., Boehnke M., Stringham H.M.; EPIC-CVD Consortium, Frossard P., Newton-Cheh C.; CHARGE+ Exome Chip Blood Pressure Consortium, Tobin M.D., Nordestgaard B.G.; T2D-GENES Consortium; GoT2DGenes Consortium; ExomeBP Consortium; CHD Exome+ Consortium, Caulfield M.J., Mahajan A., Morris A.P., Tomaszewski M., Samani N.J., Saleheen D., Asselbergs F.W., Lindgren C.M., Danesh J., Wain L.V., Butterworth A.S., Howson J.M., Munroe P.B. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat Genet. 2016;48(10):1151-1161. PMID: 27618447, PMCID: PMC5056636. https://doi.org/10.1038/ng.3654
  17. Tian X., Zhang Q., Huang Y., Chen S., Tang C., Sun Y., Du J., Jin H. Endothelin-1 downregulates sulfur dioxide/aspartate aminotransferase pathway via reactive oxygen species to promote the proliferation and migration of vascular smooth muscle cells. Oxid Med Cell Longev. 2020;2020:9367673. PMID: 32089786, PMCID: PMC7008293. https://doi.org/10.1155/2020/9367673
  18. Balbino K.P., Hermsdorff H.H.M., Bressan J. Polymorphism related to cardiovascular risk in hemodialysis subjects: a systematic review. J Bras Nefrol. 2018;40(2):179-192. PMID: 29944163, PMCID: PMC6533983. https://doi.org/10.1590/2175-8239-jbn-3857
  19. Ying C.-Q., Wang Y.-H., Wu Z.-L., Fang M.-W., Wang J., Li Y.-S., Zhang Y.-H., Qiu C.-C. Association of the renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the mongolian population. Clin Exp Hypertens. 2010;32(5):293-300. PMID: 20662730. https://doi.org/10.3109/10641960903443517
  20. Shankarishan P., Borah P.K., Mahanta J. Renin-angiotensin system gene polymorphisms and hypertension. J Assoc Physicians India. 2018;66(8):79-84. PMID: 31324091.
  21. Roush G.C., Abdelfattah R., Song S., Ernst M.E., Sica D.A., Kostis J.B. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2018;20(10):1507-1515. PMID: 30251403. https://doi.org/10.1111/jch.13386
  22. Кох Н.В., Слепухина А.А., Лифшиц Г.И. Артериальная гипертония: молекулярно-генетические и фармакогенетические подходы. Фармакогенетика и фармакогеномика. 2015;2:4-8. [Kokh N.V., Slepukhina A.A., Lifshits G.I. Arterial hypertension: molecular genetic and pharmacogenetic approaches. Pharmacogenetics and pharmacogenomics. 2015;2:4-8. (In Russ.)]